GSI 150 (Zydelig 150 mg)
Generic Name: idelalisib
Pill imprint GSI 150 has been identified as Zydelig 150 mg.
Zydelig is used in the treatment of non-hodgkin's lymphoma; follicular lymphoma; chronic lymphocytic leukemia; lymphoma and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Zydelig 150 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- idelalisib
- Imprint:
- GSI 150
- Strength:
- 150 mg
- Color:
- Pink
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Multikinase inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Gilead Sciences, Inc.
More about Zydelig (idelalisib)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: multikinase inhibitors
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
